Presence of Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Germany

被引:0
|
作者
G. Bierbaum
K. Fuchs
W. Lenz
C. Szekat
H. -G. Sahl
机构
[1] Nationales Referenzzentrum für Staphylokokken,
[2] Institut für Medizinische Mikrobiologie und Immunologie der Universität Bonn,undefined
[3] Sigmund-Freud-Straße 25,undefined
[4] D-53125 Bonn,undefined
[5] Germany e-mail: g.bierbaum@mibi03.meb.uni-bonn.de,undefined
关键词
Cell Wall; Vancomycin; Staphylococcus Aureus; Culture Collection; Susceptibility Testing;
D O I
暂无
中图分类号
学科分类号
摘要
 A total of 457 Staphylococcus aureus strains from the culture collection of the National Reference Center for Staphylococci in Bonn, Germany, were screened for susceptibility to vancomycin because some Staphylococcus aureus strains are able to form subpopulations that show intermediate resistance to vancomycin. Two methicillin-resistant Staphylococcus aureus strains (isolated in 1993) exhibited intermediate resistance. One of these, Staphylococcus aureus 137-93, which displayed the genomic DNA fragment pattern of the northern German epidemic strain, appeared homogeneously resistant. Neither of these strains had been identified by routine susceptibility testing. The resistance of the German isolates was lower than that of the Japanese isolate Mu50. To determine whether a similar mechanism confers vancomycin resistance in Staphylococcus aureus Mu50 and 137-93, the intracellular cell wall precursor concentration was measured and was not found to be comparably increased in Staphylococcus aureus 137-93. In conclusion, strains showing intermediate resistance have been present in Germany for some time (at least since 1993), but the subpopulations with decreased sensitivity were overlooked during antibiotic susceptibility testing.
引用
收藏
页码:691 / 696
页数:5
相关论文
共 50 条
  • [21] Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
    Park, Jung Wan
    Lee, Hyungmin
    Kim, Jung Wook
    Kim, Bongyoung
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus
    Shoji, Mitsutaka
    Cui, Longzhu
    Iizuka, Risa
    Komoto, Akira
    Neoh, Hui-min
    Watanabe, Yukiko
    Hishinuma, Tomomi
    Hiramatsu, Keiichi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (08) : 3870 - 3881
  • [24] Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
    Lin, Chien-Yu
    Wang, Jui-Hsing
    Lin, Kai-Hsiang
    Ho, Yu-Ling
    Ho, Cheng-Mao
    TZU CHI MEDICAL JOURNAL, 2018, 30 (03): : 135 - 140
  • [25] Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada
    Webster, Duncan
    Rennie, Robert P.
    Brosnikoff, Cheryl L.
    Chui, Linda
    Brown, Connie
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 57 (02) : 177 - 181
  • [26] Development of Reduced Vancomycin Susceptibility in Methicillin-Susceptible Staphylococcus aureus
    Pillai, Satish K.
    Wennersten, Christine
    Venkataraman, Lata
    Eliopoulos, George M.
    Moellering, Robert C., Jr.
    Karchmer, Adolf W.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : 1169 - 1174
  • [27] Evaluating vancomycin susceptibility in Staphylococcus aureus
    Mimica, Marcelo J.
    Navarini, Alessandra
    INFECTION AND DRUG RESISTANCE, 2016, 9 : 239 - 240
  • [28] Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
    Cui, LZ
    Tominaga, E
    Neoh, HM
    Hiramatsu, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 1079 - 1082
  • [29] Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro
    Xu, Jia
    Pang, Long
    Ma, Xiao Xue
    Hu, Jian
    Tian, Yuan
    Yang, Ya Li
    Sun, Dan Dan
    OPEN MEDICINE, 2018, 13 (01): : 475 - 486
  • [30] Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia
    Rotun, SS
    McMath, V
    Schoonmaker, DJ
    Maupin, PS
    Tenover, FC
    Hill, BC
    Ackman, DM
    EMERGING INFECTIOUS DISEASES, 1999, 5 (01) : 147 - 149